Company research / DWTX

Dogwood Therapeutics, Inc. (DWTX)

Build a valuation ↗↓ Download CSV

CIK 0001818844

Key ratios (year ended 2025-12-31)

-45.7%

Return on year-end equity

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: 10-Q · 2026-08-14

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. A dash means a matching observation is unavailable.

Period ended	2025-12-31	2024-12-31	2024-10-09	2024-10-08	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31
Operating Income	-$27.97M	-$12.23M	—	—	-$5.45M	-$12.32M	-$15.64M	-$10.01M	—
Net Income	-$34.26M	-$12.35M	—	—	-$5.30M	-$12.25M	-$15.96M	-$10.35M	—
EPS (Diluted)	$-7.13	$-12.52	—	—	$-7.05	$-1.11	$-1.92	$-2.10	—
Total Assets	$90.17M	$94.31M	—	—	$4.17M	$8.37M	$15.78M	$31.47M	—
Total Liabilities	$15.27M	$30.03M	—	—	$358.5K	$1.04M	$1.28M	$1.53M	—
Shareholders' Equity	$74.90M	-$10.12M	—	—	$3.81M	$7.33M	$14.50M	$29.94M	-$5.02M
Cash & Equivalents	$6.52M	$14.85M	—	—	$3.32M	$7.03M	$14.01M	$29.80M	—
Operating Cash Flow	-$15.62M	-$8.79M	—	—	-$4.87M	-$11.47M	-$15.69M	-$3.90M	—
Shares Outstanding	29.74M	1.33M	1.11M	27.76M	770.3K	18.33M	8.33M	8.31M	—
Weighted Average Diluted Shares	4.98M	1.03M	—	—	751.1K	11.07M	8.33M	4.93M	—
EPS (Basic)	$-7.13	$-12.52	—	—	$-7.05	$-1.11	$-1.92	$-2.10	—